People Otto Boerman

Profile

prof. dr. Otto Boerman



About Otto Boerman

Name                                     : Otto Christiaan Boerman

Date and place of birth          : May 27, 1959 in Lochem, The Netherlands

Address (work)                     : CDL, Radboud Univ Med Center

                                               P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Address (home)                     : Kopacker 72, 6581 JW Malden, The Netherlands

Phone                                    : +31-24-3613813 (work)

                                              : +31-24-3881745 (home)

E-mail address                       : Otto.Boerman@radboudumc.nl

H-index                                 : 70

 

Current Position

 

Director of Facility for Research with Laboratory Animals of Radboud University Medical Center Nijmegen, the Netherlands. Professor Radiochemistry Radboud University Medical Center Nijmegen

 

 

Awards and prizes:

1994   Marie Curie Award (European Association of Nuclear Medicine) for “Infectious and inflammatory disease imaging with labeled Interleukins”

1997   Amersham Health Care Award (International Society Of Radiolabeled Blood Elements) for “Infectious and inflammatory disease imaging with labeled Interleukins” (group)

1997   Jean Debiesse Award (European Association of Nuclear Medicine) for “Infectious and inflammatory disease imaging with labeled Interleukins”

1999   Jean Debiesse Award (European Association of Nuclear Medicine) for “Infectious and inflammatory disease imaging with labeled liposomes” (group)

2000   Best basic science paper in Journal of Nuclear Medicine.Steffens MG, Oosterwijk E, Kranenborg MH, Manders JM, Debruyne FM, Corstens FH, Boerman OC.  In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med. 1999;40:829-836.

2011   EANM Springer Prize for Most Cited Paper 2010. (European Association of Nuclear Medicine) for the manuscript by Dijkgraaf  et al., Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides. European Journal of Nuclear Medicine and Molecular Imaging 2007; 34: 267-273 (group)

2011   Marie Curie Award (European Association of Nuclear Medicine) for “Longitudinal imaging of transplanted islets in a rat model with SPECT”

2011   Woldring Prize (Dutch Society of Nuclear Medicine, NVNG) for the best Dutch PhD-thesis in nuclear medicine 2010 “Adjuvant radioimmunotherapy in experimental colorectal cancer” by Dr. G.M. de Jong (promotor)

2014   Best basic science paper in Eur Urol. Muselaers CH, Boerman OC, Oosterwijk E, Langenhuijsen JF, Oyen WJ, Mulders PF. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. Eur Urol. 2013;63:1101-1106.

2019 Woldring Prize (Dutch Society of Nuclear Medicine, NVNG) for the best Dutch PhD-thesis in nuclear medicine 2010 “Tumor-targeted Imaging of cancer with radiolabeled and fluorescently labeled antibodies” by Dr. M. Hekman (promotor)

 

 

 

Otto C. Boerman (Lochem, 25 May 1959, H-index: 70) studied Chemistry at the University of Nijmegen (1977-1884). From 1985 until 1990, he was a junior investigator at the Department of Cell Biology at the University of Nijmegen, where he wrote his thesis, entitled ‘Development and Application of Monoclonal Antibodies Against Ovarian Carcinoma-Associated Antigens.’

As a fellow of the Dutch Cancer Society he worked at the Center for Molecular Medicine and Immunology in Newark, NJ (1990-1991) on targeting cancer with radiolabeled monoclonal antibodies (Head: Dr. D.M. Goldenberg). He then worked at the Biological Response Modifiers Program of the National Institutes of Health in Frederick, MD (1991-1992) on the in vivo effects of IL-7 (Head: Dr. D. Longo). When he returned to The Netherlands in 1992, he started his preclinical research group at the Department of Nuclear Medicine of the Radboud University Nijmegen Medical Center. In his group preclinical research focused on radionuclide imaging and radionuclide therapy with radiolabeled antibodies and peptides  In 2007 he became a full professor in Radiochemistry at the Radboud University Nijmegen. He was (co-)promoter of 41 PhD candidates. He is a (co-)author of more than 495 peer reviewed scientific publications. In 2017 he was appointed as director of the Facility for research with laboratory animals (CDL) of the Radboud university Medical Center in Nijmegen.


Positions

  • hoofd CDL

Research Institute Radboud Institute for Molecular Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more